Steward Partners Investment Advisory, LLC Nektar Therapeutics Transaction History
Steward Partners Investment Advisory, LLC
- $8.95 Billion
- Q1 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 200 shares of NKTR stock, worth $234. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$234
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NKTR
# of Institutions
128Shares Held
111MCall Options Held
150KPut Options Held
4K-
Deep Track Capital, LP Greenwich, CT18.4MShares$21.5 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$14.1 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA7.57MShares$8.86 Million0.02% of portfolio
-
Primecap Management CO Pasadena, CA6.97MShares$8.15 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.88MShares$6.88 Million0.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $219M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...